Australia's Clinuvel jumps on expansion of Singapore R&D hub

Clinuvel Pharmaceuticals

07/12/2025 23:55

** Shares of Clinuvel Pharmaceuticals CUV.AX advances 2.35% to A$12.620, their highest since December 1

** Biopharma co announces significant expansion of Vallaurix research, development and innovation hub in Singapore

** Adds, backed by Singapore's Economic Development Board, the site will integrate formulation and analytical sciences to advance controlled-release peptide drugs, a key plank in co's vertical integration strategy

** Stock up 4.1% YTD

 (Reporting by Kumar Tanishk in Bengaluru)

 ((Tanishk.Kumar@thomsonreuters.com; X: @thatstanishk http://www.x.com/thatstanishk;))